Assignee profile:

Depomed, Inc.

City:

Newark, California

Country:

United States

Published Applications:

33

Last publication date:

2017-05-25

Patent Grants:

28

Last grant date:

2018-04-10

Top Inventors for applications by Depomed, Inc.

These are the the leading inventors for applications assigned to Depomed, Inc.:

Recent patent applications by Depomed, Inc.

Depomed, Inc. based in Newark, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2017-05-25 ✅ Patent 9,937,142 granted on 2018-04-10
US20170143654A1
Human necessities

Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders

#2 | 2016-06-30 ✅ Patent 9,801,816 granted on 2017-10-31
US20160184224A1
Human necessities

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

#3 | 2016-02-04 ✅ Patent 9,572,780 granted on 2017-02-21
US20160030352A1
Human necessities

Dual drug dosage forms with improved separation of drugs

#4 | 2015-12-31 ✅ Patent 9,566,258 granted on 2017-02-14
US20150374653A1
Human necessities

Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders

#5 | 2015-10-08 ✅ Patent 9,814,705 granted on 2017-11-14
US20150283123A1
Human necessities

Intranasal spray device containing pharmaceutical composition

#6 | 2015-07-02 ✅ Patent 9,597,338 granted on 2017-03-21
US20150182541A1
Human necessities

Shell-and-core dosage form approaching zero-order drug release

#7 | 2015-06-18 ✅ Patent 9,301,934 granted on 2016-04-05
US20150164832A1
Human necessities

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

#8 | 2014-07-03 ✅ Patent 8,999,388 granted on 2015-04-07
US20140186515A1
Human necessities

Dual drug dosage forms with improved separation of drugs

#9 | 2014-07-03
US20140186440A1
Human necessities

GASTRIC RETENTIVE EXTENDED-RELEASE DOSAGE FORMS COMPRISING COMBINATIONS OF A NON-OPIOID ANALGESIC AND AN OPIOID ANALGESIC

#10 | 2014-05-15
US20140135395A1
Human necessities

GASTRIC RETENTIVE GABAPENTIN DOSAGE FORMS AND METHODS FOR USING SAME

#11 | 2014-04-17 ✅ Patent 9,561,200 granted on 2017-02-07
US20140107210A1
Human necessities

Method of treating post-surgical acute pain

#12 | 2014-03-13
US20140072623A1
Human necessities

GASTRIC RETAINED GABAPENTIN DOSAGE FORM

#13 | 2014-03-06
US20140066411A1
Human necessities

PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF AZO-BONDED 5-AMINOSALICYLIC ACID COMPOSITIONS

#14 | 2013-11-28
US20130316002A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL MOTILITY DYSFUNCTION

#15 | 2013-11-14 ✅ Patent 8,802,157 granted on 2014-08-12
US20130302417A1
Human necessities

Methods of treatment using a gastric retained gabapentin dosage form

#16 | 2013-08-29 ✅ Patent 8,580,303 granted on 2013-11-12
US20130224289A1
Human necessities

Gastric retained gabapentin dosage form

#17 | 2013-06-27 ✅ Patent 8,945,619 granted on 2015-02-03
US20130164377A1
Human necessities

Shell-and-core dosage form approaching zero-order drug release

#18 | 2013-05-09 ✅ Patent 8,592,481 granted on 2013-11-26
US20130116320A1
Human necessities

Gastric retentive gabapentin dosage forms and methods for using same

#19 | 2012-12-20 ✅ Patent 8,668,929 granted on 2014-03-11
US20120321713A1
Human necessities

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#20 | 2012-11-01 ✅ Patent 8,889,176 granted on 2014-11-18
US20120277267A1
Human necessities

Method of managing or treating pain

#21 | 2012-10-25 ✅ Patent 9,078,814 granted on 2015-07-14
US20120270903A1
Human necessities

Intranasal spray device containing pharmaceutical composition

#22 | 2012-10-18 ✅ Patent 8,685,450 granted on 2014-04-01
US20120263792A1
Human necessities

Dual drug dosage forms with improved separation of drugs

#23 | 2012-06-14 ✅ Patent 8,409,613 granted on 2013-04-02
US20120148671A1
Human necessities

Gastric retained gabapentin dosage form

#24 | 2012-05-31 ✅ Patent 8,394,408 granted on 2013-03-12
US20120136022A1
Human necessities

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#25 | 2012-05-24 ✅ Patent 8,475,813 granted on 2013-07-02
US20120128735A1
Human necessities

Methods of treatment using a gastric retained gabapentin dosage

#26 | 2012-03-29 ✅ Patent 9,000,046 granted on 2015-04-07
US20120077878A1
Human necessities

Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract

#27 | 2012-03-15 ✅ Patent 8,529,955 granted on 2013-09-10
US20120064168A1
Human necessities

Methods of treatment using a gastric retained gabapentin dosage

#28 | 2012-02-02 ✅ Patent 8,440,232 granted on 2013-05-14
US20120027823A1
Human necessities

Methods of treatment using a gastric retained gabapentin dosage

#29 | 2011-12-08 ✅ Patent 9,980,903 granted on 2018-05-29
US20110301129A1
Human necessities

Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract

#30 | 2011-12-08 ✅ Patent 8,623,920 granted on 2014-01-07
US20110300207A1
Human necessities

Method of treating post-surgical acute pain

#31 | 2010-08-05 ✅ Patent 8,372,432 granted on 2013-02-12
US20100196474A1
Human necessities

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

#32 | 2010-02-18 ✅ Patent 9,161,911 granted on 2015-10-20
US20100040689A1
Human necessities

Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders

#33 | 2010-01-21 ✅ Patent 8,377,453 granted on 2013-02-19
US20100015222A1
Human necessities

Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic

Also check out Depomed, Inc.'s (Newark, United States) applicant profile with 13 patent applications submitted.

AssigneeID:

21876 ⎘